Gambia vs Niger: Cause of death, by non-communicable diseases, ages 15-59, female
Gambia
38.3%
in 2021
Niger
40.5%
in 2021
Gambia rank
167th
Niger rank
164th
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Gambia
- Niger
How they compare
Niger currently reports 40.5% against 38.3% in Gambia, a difference of 2.2%.
That makes Niger's figure about 1.1 times Gambia's.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Gambia ahead.
Gambia ranks 167th and Niger ranks 164th of 185 countries.
Across the 3 decades both report, Gambia averaged higher in 1 and Niger in 2.
Head to head by decade
| Decade | Gambia | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.9% | 28.7% | 1.2% | Gambia |
| 2010s | 35.7% | 39.1% | 3.4% | Niger |
| 2020s | 38.9% | 40.9% | 2.1% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Gambia or Niger?
- Niger, at 40.5% against 38.3% in Gambia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Gambia and Niger?
- 2.2%, with Niger ahead.
- How many years of comparable data are there for Gambia and Niger?
- 6 years are reported by both, from 2000 to 2021.
- How do Gambia and Niger rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Gambia ranks 167th and Niger ranks 164th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.